Piramal Pharma Limited has reported Consolidated financial results for the period ended June 30, 2023.

The company has posted net loss of Rs. 98.58 crores for the period ended June 30, 2023 as against net profit of Rs. 50.11 crores for the period ended March 31, 2023. It posted net loss of Rs. 109.05 crores for the period ended June 30, 2022.

The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023 as compared to Rs. 2188.08 crores during the period ended March 31, 2023. It reported total income of Rs.1553.84 crores during the period ended June 30, 2022.